I knew I wanted to work with children long before I wanted to be a physician. Their innocence and potential encourage me to inspire the next generation who could, ultimately, change the world.
As a pediatric endocrinologist, I treat all endocrine conditions, however, I work in some special areas. These special areas include congenital hypothyroidism and Type 1 diabetes. I’m very invested in health disparities which occur in children with diabetes. I am especially passionate about equal access to healthcare for patients who are at high risk for complications from diabetes.
I believe that disease and illness are not what define you — instead, it’s your life experiences. So, if you don't take your medicine because your insurance company doesn't cover it, I understand. If you missed your appointment because you don't have transportation, I empathize. I work to change my healthcare delivery to meet the needs of my patients.
In my research, I seek ways to improve the health outcomes of all children with chronic diseases, such as Type 1 diabetes.
During my free time, I am very active in community service. I explore my passion for healthcare beyond the hospital walls of Cincinnati Children’s.
MD: University of Louisville School of Medicine, Louisville, KY, 2002.
Residency: Pediatrics, Washington University, St. Louis Children’s Hospital, St. Louis, MO, 2005.
Chief Residency: Pediatrics, Washington University, St. Louis Children’s Hospital, St. Louis, MO, 2006.
Fellowship: Pediatrics, Washington University, St. Louis Children’s Hospital, St. Louis, MO, 2009.
Health equity - health is a fundamental human right. Health equity is achieved when everyone, no matter the circumstance, has access to quality of life; diabetes - reducing health inequities in the care of diabetes patients and clinical care in diabetes, especially improving access to diabetes technology; diabetes technology - improving access to diabetes technology for the most vulnerable of patients; congenital hypothyroidism - ensuring all pediatric patients, especially those ages 0-3, receive adequate diagnosis and treatment of thyroid disease; quality improvement - using quality improvement methodology to improve the lives of children with any endocrine disease; perioperative diabetes care - systematic development of protocols to ensure safe procedural outcomes for children with diabetes
Health disparities; quality improvement; health equity
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Associations of prenatal and postnatal exposure to perfluoroalkyl substances with pubertal development and reproductive hormones in females and males: The HOME study. Science of the Total Environment. 2023; 890:164353.
Factors Associated With Achieving Target A1C in Children and Adolescents With Type 1 Diabetes: Findings From the T1D Exchange Quality Improvement Collaborative. Clinical diabetes : a publication of the American Diabetes Association. 2023; 41:68-75.
Implicit Racial-Ethnic and Insurance-Mediated Bias to Recommending Diabetes Technology: Insights from T1D Exchange Multicenter Pediatric and Adult Diabetes Provider Cohort. Diabetes Technology and Therapeutics. 2022; 24:619-627.
Trends in Type 1 Diabetic Ketoacidosis During COVID-19 Surges at 7 US Centers: Highest Burden on non-Hispanic Black Patients. Journal of Clinical Endocrinology and Metabolism. 2022; 107:1948-1955.
Socioeconomic and Racial Disparities in Diabetic Ketoacidosis Admissions in Youth With Type 1 Diabetes. Journal of hospital medicine (Online). 2021; 16:517-523.
Seven practices for pursuing equity through learning health systems: Notes from the field. Learning Health Systems. 2021; 5:e10279.
Multi-Clinic Quality Improvement Initiative Increases Continuous Glucose Monitoring Use Among Adolescents and Young Adults With Type 1 Diabetes. Clinical diabetes : a publication of the American Diabetes Association. 2021; 39:264-271.
Inequities in Health Outcomes in Children and Adults With Type 1 Diabetes: Data From the T1D Exchange Quality Improvement Collaborative. Clinical diabetes : a publication of the American Diabetes Association. 2021; 39:278-283.
Inequities in Diabetic Ketoacidosis Among Patients With Type 1 Diabetes and COVID-19: Data From 52 US Clinical Centers. Journal of Clinical Endocrinology and Metabolism. 2021; 106:e1755-e1762.
Treatment-Induced Neuropathy of Diabetes in Youth: Case Series of a Heterogeneous and Challenging Complication. Journal of the Endocrine Society. 2020; 4:bvaa154.
Nana-Hawa Yayah Jones, MD4/5/2022
Nana-Hawa Yayah Jones, MD9/28/2021